Literature DB >> 15296697

Therapeutic reduction of coronary atheromatous plaque burden using bioengineered apoA-I Milano.

Peter P Toth1.   

Abstract

Entities:  

Year:  2004        PMID： 15296697     DOI： 10.1007/s11883-004-0042-5

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  15 in total

Review 1.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  High-density lipoprotein and cardiovascular risk.

Authors:  Peter P Toth
Journal:  Circulation       Date:  2004-04-20       Impact factor: 29.690

Review 3.  Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update.

Authors:  Antonio M Gotto; Eliot A Brinton
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

4.  Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

Authors:  R K Tangirala; K Tsukamoto; S H Chun; D Usher; E Puré; D J Rader
Journal:  Circulation       Date:  1999-10-26       Impact factor: 29.690

5.  Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Authors:  S J Robins; D Collins; J T Wittes; V Papademetriou; P C Deedwania; E J Schaefer; J R McNamara; M L Kashyap; J M Hershman; L F Wexler; H B Rubins
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

6.  High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.

Authors:  P K Shah; J Yano; O Reyes; K Y Chyu; S Kaul; C L Bisgaier; S Drake; B Cercek
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

7.  Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

Authors:  Giulia Chiesa; Elena Monteggia; Marta Marchesi; Paolo Lorenzon; Massimo Laucello; Vito Lorusso; Carlo Di Mario; Evangelia Karvouni; Roger S Newton; Charles L Bisgaier; Guido Franceschini; Cesare R Sirtori
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

Review 8.  Apolipoprotein A-I(Milano): current perspectives.

Authors:  Giulia Chiesa; Cesare R Sirtori
Journal:  Curr Opin Lipidol       Date:  2003-04       Impact factor: 4.776

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits.

Authors:  A Miyazaki; S Sakuma; W Morikawa; T Takiue; F Miake; T Terano; M Sakai; H Hakamata; Y Sakamoto; M Natio
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.